ID
24139
Description
Study ID: 100468 Clinical Study ID: AVA100468 Study Title: An open-label extension to study AVA100193, to assess the long-term safety and efficacy of rosiglitazone (extended release tablets) in subjects with mild to moderate Alzheimer's disease Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 2 Study Recruitment Status: Completed Generic Name: rosiglitazone Trade Name: Avandia XR,Avandia; Avandia XR,Rosiglitazone XR,Avandia Study Indication: Alzheimer's Disease Early Withdrawal Follow-Up
Keywords
Versions (1)
- 7/25/17 7/25/17 -
Copyright Holder
GlaxoSmithKline
Uploaded on
July 25, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC-ND 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Early Withdrawal Follow-Up GSK Rosiglitazone Alzheimer's disease 100468
Early Withdrawal Follow-Up GSK Rosiglitazone Alzheimer's disease 100468
Description
Visit Information
Alias
- UMLS CUI-1
- C0545082
Description
Investigator Instructions
Alias
- UMLS CUI-1
- C1442085
Description
Vital Signs
Alias
- UMLS CUI-1
- C0518766
Description
Weight
Data type
float
Measurement units
- kg
Alias
- UMLS CUI [1]
- C0005910
Description
Blood pressure and heart rate will be measured once, after the subject sits quietly for at least 5 minutes.
Data type
float
Measurement units
- mmHg
Alias
- UMLS CUI [1]
- C0871470
Description
Blood pressure and heart rate will be measured once, after the subject sits quietly for at least 5 minutes.
Data type
float
Measurement units
- mmHg
Alias
- UMLS CUI [1]
- C0428883
Description
Blood pressure and heart rate will be measured once, after the subject sits quietly for at least 5 minutes.
Data type
float
Measurement units
- beats/minute
Alias
- UMLS CUI [1]
- C0018810
Description
Central Laboratory (Non Fasting Samples)
Alias
- UMLS CUI-1
- C1880016
Description
Concomitant Medication
Alias
- UMLS CUI-1
- C2347852
Description
Adverse Event
Alias
- UMLS CUI-1
- C0877248
Description
Adverse Event
Data type
text
Alias
- UMLS CUI [1]
- C0877248
Description
Physical Examination
Alias
- UMLS CUI-1
- C0031809
Description
Physical Examination
Data type
text
Alias
- UMLS CUI [1]
- C0031809
Description
Pedal Oedema
Alias
- UMLS CUI-1
- C0574002
Description
Pedal Oedema: depth
Data type
integer
Alias
- UMLS CUI [1,1]
- C0574002
- UMLS CUI [1,2]
- C0205125
Description
Pedal Oedema: Site
Data type
integer
Alias
- UMLS CUI [1,1]
- C0574002
- UMLS CUI [1,2]
- C1515974
Description
End of Study Assessment
Alias
- UMLS CUI-1
- C0444496
Similar models
Early Withdrawal Follow-Up GSK Rosiglitazone Alzheimer's disease 100468
C1442085 (UMLS CUI-2)
C1442085 (UMLS CUI [1,2])
C0205125 (UMLS CUI [1,2])
C1515974 (UMLS CUI [1,2])